Literature DB >> 26544982

Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate.

Morgan E Grams1, Yingying Sang, Andrew S Levey, Kunihiro Matsushita, Shoshana Ballew, Alex R Chang, Eric K H Chow, Bertram L Kasiske, Csaba P Kovesdy, Girish N Nadkarni, Varda Shalev, Dorry L Segev, Josef Coresh, Krista L Lentine, Amit X Garg.   

Abstract

BACKGROUND: Evaluation of candidates to serve as living kidney donors relies on screening for individual risk factors for end-stage renal disease (ESRD). To support an empirical approach to donor selection, we developed a tool that simultaneously incorporates multiple health characteristics to estimate a person's probable long-term risk of ESRD if that person does not donate a kidney.
METHODS: We used risk associations from a meta-analysis of seven general population cohorts, calibrated to the population-level incidence of ESRD and mortality in the United States, to project the estimated long-term incidence of ESRD among persons who do not donate a kidney, according to 10 demographic and health characteristics. We then compared 15-year projections with the observed risk among 52,998 living kidney donors in the United States.
RESULTS: A total of 4,933,314 participants from seven cohorts were followed for a median of 4 to 16 years. For a 40-year-old person with health characteristics that were similar to those of age-matched kidney donors, the 15-year projections of the risk of ESRD in the absence of donation varied according to race and sex; the risk was 0.24% among black men, 0.15% among black women, 0.06% among white men, and 0.04% among white women. Risk projections were higher in the presence of a lower estimated glomerular filtration rate, higher albuminuria, hypertension, current or former smoking, diabetes, and obesity. In the model-based lifetime projections, the risk of ESRD was highest among persons in the youngest age group, particularly among young blacks. The 15-year observed risks after donation among kidney donors in the United States were 3.5 to 5.3 times as high as the projected risks in the absence of donation.
CONCLUSIONS: Multiple demographic and health characteristics may be used together to estimate the projected long-term risk of ESRD among living kidney-donor candidates and to inform acceptance criteria for kidney donors. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.).

Entities:  

Mesh:

Year:  2015        PMID: 26544982      PMCID: PMC4758367          DOI: 10.1056/NEJMoa1510491

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  30 in total

1.  When good intentions are not enough: obtaining follow-up data in living kidney donors.

Authors:  E S Ommen; D LaPointe Rudow; R K Medapalli; B Schröppel; B Murphy
Journal:  Am J Transplant       Date:  2011-11-04       Impact factor: 8.086

Review 2.  Living kidney donation: outcomes, ethics, and uncertainty.

Authors:  Peter P Reese; Neil Boudville; Amit X Garg
Journal:  Lancet       Date:  2015-05-16       Impact factor: 79.321

3.  Mortality and cardiovascular disease among older live kidney donors.

Authors:  P P Reese; R D Bloom; H I Feldman; P Rosenbaum; W Wang; P Saynisch; N M Tarsi; N Mukherjee; A X Garg; A Mussell; J Shults; O Even-Shoshan; R R Townsend; J H Silber
Journal:  Am J Transplant       Date:  2014-07-09       Impact factor: 8.086

4.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

5.  Perioperative mortality and long-term survival following live kidney donation.

Authors:  Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery
Journal:  JAMA       Date:  2010-03-10       Impact factor: 56.272

Review 6.  Shifting paradigms in eligibility criteria for live kidney donation: a systematic review.

Authors:  Ali R Ahmadi; Jeffrey A Lafranca; Laura A Claessens; Raoul M S Imamdi; Jan N M IJzermans; Michiel G H Betjes; Frank J M F Dor
Journal:  Kidney Int       Date:  2014-04-30       Impact factor: 10.612

7.  'Normal for now' or 'at future risk': a double standard for selecting young and older living kidney donors.

Authors:  R W Steiner
Journal:  Am J Transplant       Date:  2010-02-25       Impact factor: 8.086

Review 8.  Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review.

Authors:  A Young; L Storsley; A X Garg; D Treleaven; C Y Nguan; M S Cuerden; M Karpinski
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

9.  Body mass index in 1.2 million adolescents and risk for end-stage renal disease.

Authors:  Asaf Vivante; Eliezer Golan; Dorit Tzur; Adi Leiba; Amir Tirosh; Karl Skorecki; Ronit Calderon-Margalit
Journal:  Arch Intern Med       Date:  2012-11-26

10.  Estimating the long term impact of kidney donation on life expectancy and end stage renal disease.

Authors:  Bryce A Kiberd
Journal:  Transplant Res       Date:  2013-02-16
View more
  114 in total

1.  Transplantation: New tool for prediction of ESRD risk in living kidney donor candidates.

Authors:  Ellen F Carney
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

2.  Risk of ESKD in Older Live Kidney Donors with Hypertension.

Authors:  Fawaz Al Ammary; Xun Luo; Abimereki D Muzaale; Allan B Massie; Deidra C Crews; Madeleine M Waldram; Mohamud A Qadi; Jacqueline Garonzik-Wang; Macey L Henderson; Daniel C Brennan; Alexander C Wiseman; Richard C Lindrooth; Jon J Snyder; Josef Coresh; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-25       Impact factor: 8.237

Review 3.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

4.  Larger nephron size, low nephron number, and nephrosclerosis on biopsy as predictors of kidney function after donating a kidney.

Authors:  Naim Issa; Lisa E Vaughan; Aleksandar Denic; Walter K Kremers; Harini A Chakkera; Walter D Park; Arthur J Matas; Sandra J Taler; Mark D Stegall; Joshua J Augustine; Andrew D Rule
Journal:  Am J Transplant       Date:  2019-02-01       Impact factor: 8.086

5.  Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Authors:  Krista L Lentine; Farrukh M Koraishy; Nagaraju Sarabu; Abhijit S Naik; Ngan N Lam; Amit X Garg; David Axelrod; Zidong Zhang; Gregory P Hess; Bertram L Kasiske; Dorry L Segev; Macey L Henderson; Allan B Massie; Courtenay M Holscher; Mark A Schnitzler
Journal:  Clin Transplant       Date:  2019-09-08       Impact factor: 2.863

6.  Obesity increases the risk of end-stage renal disease among living kidney donors.

Authors:  Jayme E Locke; Rhiannon D Reed; Allan Massie; Paul A MacLennan; Deirdre Sawinski; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Cora E Lewis; Dorry L Segev
Journal:  Kidney Int       Date:  2016-12-29       Impact factor: 10.612

7.  Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis.

Authors:  S Ansari; M B Bromberg; S B Gibson
Journal:  Clin Neurol Neurosurg       Date:  2017-07-05       Impact factor: 1.876

8.  Perceptions, motivations, and concerns about living organ donation among people living with HIV.

Authors:  Sarah E Van Pilsum Rasmussen; Macey L Henderson; Juli Bollinger; Shanti Seaman; Diane Brown; Christine M Durand; Dorry L Segev; Jeremy Sugarman
Journal:  AIDS Care       Date:  2018-05-03

9.  Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Authors:  Csaba P Kovesdy; Kunihiro Matsushita; Yingying Sang; Nigel J Brunskill; Juan J Carrero; Gabriel Chodick; Takeshi Hasegawa; Hiddo L Heerspink; Atsushi Hirayama; Gijs W D Landman; Adeera Levin; Dorothea Nitsch; David C Wheeler; Josef Coresh; Stein I Hallan; Varda Shalev; Morgan E Grams
Journal:  Eur Heart J       Date:  2018-05-01       Impact factor: 29.983

10.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.